Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideZBHZimmer Biomet
FinDog View：Neutral
| Metric | ABBV | ZBH |
|---|
| Close | 262.51 | 96.78 |
| Market Cap | $464B | $18.4B |
| 1M | +4.87% | −1.45% |
| P/E (TTM) | 73.7 | 22.1 |
| Forward P/E | 16.8 | 10.8 |
| P/E 5-Yr Percentile | 51 | 25 |
| P/S | 7.2 | 2.1 |
| P/B | — | 1.4 |
| Dividend Yield | 4.47% | 1.04% |
| Latest Quarter Revenue | $17.0B | $2.2B |
| Revenue YoY | +10.2% | +4.8% |
| Gross Margin | 74.7% | 70.8% |
| Latest Quarter EPS | 2.03 | 1.03 |
| Avg Post-Earnings Move | ±1.7% | ±2.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 5.11% |
| 90-Day Net Insider Buying | −$8.2M | −$0.82M |
ABBV · Revenue, Last 8 Quarters ($B)
ZBH · Revenue, Last 8 Quarters ($B)
